6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01119131 (ClinicalTrials.gov)	May 2011	23/4/2010	Effects of Vitamin D in Parkinson's Disease (PD)	The Effects of Vitamin D on Balance in Persons With PD	Parkinson Disease;Accidental Falls	Drug: Vitamin D3;Dietary Supplement: calcium;Other: Placebo	VA Office of Research and Development	Oregon Health and Science University	Completed	50 Years	99 Years	All	101	Phase 2	United States
2	NCT00907972 (ClinicalTrials.gov)	September 2009	22/5/2009	The Effects of Vitamin D and Bone Loss in Parkinson's Disease	Effect of Vitamin D3 Supplementation in Parkinson's Disease Patients - A Pilot Study	Parkinson Disease	Dietary Supplement: Vitamin D3;Other: Placebo	Memorial Medical Center	Department of Defense	Completed	18 Years	N/A	Both	23	Phase 2	United States
3	JPRN-UMIN000001841	2009/04/01	02/04/2009	A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life		Parkinson disease	Vitamin D3 placebo	Jikei University School of Medicine	NULL	Complete: follow-up complete	45years-old	85years-old	Male and Female	120	Not selected	Japan
4	NCT00571285 (ClinicalTrials.gov)	June 2007	7/12/2007	Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease	Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease	Parkinson's Disease	Dietary Supplement: Vitamin D3;Dietary Supplement: Vitamin D3 - high dose;Dietary Supplement: Placebo	Emory University	NULL	Terminated	18 Years	89 Years	All	31	Phase 4	United States